Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Joseph A. Burns, Ph.D. ’66, emeritus professor of engineering and astronomy, and a former vice provost and dean of the Cornell faculty, died Feb. 26 in Ithaca.
The newest episode of “Startup Cornell,” a podcast hosted by Entrepreneurship at Cornell, features Josh Gully ’83, managing director of NewEdge Wealth.
A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
Joan Klein Jacobs ’54, a global philanthropist who believed strongly in the power of education and the arts to transform lives, died May 6 in San Diego. She was 91.
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.
By repeatedly scanning the brains of a small group of patients for a year and a half, Weill Cornell Medicine researchers have identified a distinct pattern of neuronal interactions that appears to predispose some people to developing depression.
Researchers from Cornell Tech have developed a method to identify delays in the reporting of incidents such as downed trees and power lines, which could lead to practical insights and interventions for more equitable, efficient government service.
Immunocompromised people with persistent COVID infections can harbor drug-resistant variants of the virus, which have the potential to spread, researchers at Weill Cornell Medicine, the College of Veterinary Medicine and the NIH have found.